[1] Maver T, et al. A review of herbal medicines in wound healing. Int J Dermatol. 2015;54(7):740-51. [2] Dong W, et al. Moringa oleifera leaf extracts improve exercise performance in young male adults: a pilot study. Phytomedicine. 2024;131:155751. [3] Zhang J, et al. Natural products and derivatives for breast cancer treatment: from drug discovery to molecular mechanism. Phytomedicine. 2024;129:155600. [4] Yu J, et al. New insight into the mechanisms of Ginkgo biloba leaves in the treatment of cancer. Phytomedicine. 2024;122:155088. [5] Yoon S, Lee B-K, Kim KP. Caffeine enhances chemosensitivity to irinotecan in the treatment of colorectal cancer. Phytomedicine. 2023;121:155120. [6] Sachdev K, Gupta MK. A comprehensive review of computational techniques for the prediction of drug side effects. Drug Dev Res. 2020;81(6):650-70. [7] Ghanbari-Movahed M, et al. Quercetin- and rutin-based nano-formulations for cancer treatment: a systematic review of improved efficacy and molecular mechanisms. Phytomedicine. 2022;97:153909. [8] Bernardo J, Valent?o P. Herb-drug interactions: a short review on central and peripheral nervous system drugs. Phytother Res. 2024;38(4):1903-31. [9] Liu L, et al. Exploring the anti-migraine effects of Tianshu capsule: chemical profile, metabolic behavior, and therapeutic mechanisms. Phytomedicine. 2024;131:155766. [10] Xu Z, et al. Why traditional herbal medicine promotes wound healing: research from immune response, wound microbiome to controlled delivery. Adv Drug Deliv Rev. 2023;195:114764. [11] Ben-Shabat S, et al. Antiviral effect of phytochemicals from medicinal plants: Applications and drug delivery strategies. Drug Deliv Transl Res. 2020;10(2):354-67. [12] Li Q, et al. Self-assembled nanodrug delivery systems for anti-cancer drugs from traditional Chinese medicine. Biomater Sci. 2024;12(7):1662-92. [13] Prasad S, Tyagi AK, Aggarwal BB. Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: the golden pigment from golden spice. Cancer Res Treat. 2014;46(1):2-18. [14] Hu L, et al. Enhancement of oral bioavailability of curcumin by a novel solid dispersion system. AAPS PharmSciTech. 2015;16(6):1327-34. [15] Walle T. Bioavailability of resveratrol. Ann N Y Acad Sci. 2011;1215:9-15. [16] Yang Z, et al. Bioavailability and pharmacokinetics of genistein: mechanistic studies on its ADME. Anticancer Agents Med Chem. 2012;12(10):1264-80. [17] Jit?reanu A, et al. Current trends in toxicity assessment of herbal medicines: a narrative review. Processes. 2023;11(1):83. [18] Philips CA, et al. Comprehensive review of hepatotoxicity associated with traditional Indian Ayurvedic herbs. World J Hepatol. 2020;12(9):574-95. [19] Yang B, et al. Nephrotoxicity and Chinese herbal medicine. Clin J Am Soc Nephrol. 2018;13(10):1605-11. [20] El-Saber Batiha G, et al. Chemical constituents and pharmacological activities of garlic (Allium sativum L.): a review. Nutrients. 2020. https://doi.org/10.3390/nu12030872. [21] Furdak P, et al. Effect of garlic extract on the erythrocyte as a simple model cell. Int J Mol Sci. 2024;25(10):5115. [22] Shaikh J, et al. Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur J Pharm Sci. 2009;37(3):223-30. [23] Jacob S, et al. Advances in nanocarrier systems for overcoming formulation challenges of curcumin: current insights. Nanomaterials. 2024;14(8):672. [24] Yen C-C, et al. Self-nanoemulsifying drug delivery system for Resveratrol: enhanced oral bioavailability and reduced physical fatigue in rats. Int J Mol Sci. 2017;18(9):1853. [25] Hosseini SH, et al. Protective effect of berberine nanoparticles against cardiotoxic effects of arsenic trioxide. Cardiovasc Toxicol. 2024;24(12):1311-6. [26] Gendy AM, et al. Berberine-loaded nanostructured lipid carriers mitigate warm hepatic ischemia/reperfusion-induced lesion through modulation of HMGB1/TLR4/NF-κB signaling and autophagy. Biomed Pharmacother. 2022;145:112122. [27] Sabit H, et al. Precision nanomedicine: navigating the tumor microenvironment for enhanced cancer immunotherapy and targeted drug delivery. Mol Cancer. 2025;24(1):160. [28] Pugazhendhi A, et al. Deciphering the importance of nanoencapsulation to improve the availability of bioactive molecules in food sources to the human body. Food Chem. 2025;464:141762. [29] Kamble MG, et al. Nanotechnology for encapsulation of bioactive components: a review. Discover Food. 2025;5(1):116. [30] Enioutina EY, et al. Phytotherapy as an alternative to conventional antimicrobials: combating microbial resistance. Expert Rev Clin Pharmacol. 2017;10(11):1203-14. [31] Bussmann R, Glenn A, Sharon D. Antibacterial activity of medicinal plants of Northern Peru - Can traditional applications provide leads for modern science? Indian J Tradit Knowled. 2010;9:742-53. [32] Albaridi NA. Antibacterial potency of honey. Int J Microbiol. 2019;2019:2464507. [33] Tayel AA, El-Tras WF. Possibility of fighting food borne bacteria by egyptian folk medicinal herbs and spices extracts. J Egypt Public Health Assoc. 2009;84(1-2):21-32. [34] Combarros-Fuertes P, et al. Honey: Another alternative in the fight against antibiotic-resistant bacteria? Antibiotics. 2020. https://doi.org/10.3390/antibiotics9110774. [35] Bishayee A, Sethi G. Bioactive natural products in cancer prevention and therapy: progress and promise. Semin Cancer Biol. 2016;40-41:1-3. [36] Huang WY, Cai YZ, Zhang Y. Natural phenolic compounds from medicinal herbs and dietary plants: potential use for cancer prevention. Nutr Cancer. 2010;62(1):1-20. [37] Aggarwal BB, et al. Potential of spice-derived phytochemicals for cancer prevention. Planta Med. 2008;74(13):1560-9. [38] Luo H, et al. Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine. Chin Med. 2019;14:48. [39] Udenigwe CC, et al. Potential of resveratrol in anticancer and anti-inflammatory therapy. Nutr Rev. 2008;66(8):445-54. [40] Weledji E. Perspectives on wound healing. Austin J Surg. 2017;4:1104. [41] Bashiri Z, et al. In-vitro and in-vivo evaluation of angiogenic potential of a novel lithium chloride loaded silk fibroin/alginate 3D porous scaffold with antibacterial activity, for promoting diabetic wound healing. Int J Biol Macromol. 2024;277:134362. [42] Pulido álvarez JA, Ca?ez Zu?iga C. Wound care and healing. Int J Med Sci Clin Res Stud. 2023;3(05):951-3. [43] Vitale S, et al. Phytochemistry and biological activity of medicinal plants in wound healing: an overview of current research. Molecules. 2022. https://doi.org/10.3390/molecules27113566. [44] Bahramsoltani R, Farzaei MH, Rahimi R. Medicinal plants and their natural components as future drugs for the treatment of burn wounds: an integrative review. Arch Dermatol Res. 2014;306(7):601-17. [45] Herman A, Herman AP. Herbal products for treatment of burn wounds. J Burn Care Res. 2020;41(3):457-65. [46] Li Q, et al. Bioactive polysaccharides from natural resources including Chinese medicinal herbs on tissue repair. Chin Med. 2018;13:7. [47] Wong H-L, et al. Application of chinese herbal medicines to revitalize adult stem cells for tissue regeneration. Chin J Integr Med. 2012;18(12):903-8. [48] Venugopal J, Sridhar S, Ramakrishna S. Electrospun plant-derived natural biomaterials for tissue engineering. Plant Sci Today. 2014;1:151-4. [49] Hanga-Farca? A, et al. Phytochemical compounds involved in the bone regeneration process and their innovative administration: a systematic review. Plants. 2023. https://doi.org/10.3390/plants12102055. [50] Tiwari A, et al. Nanophytomedicine: nanotechnology for herbal product development and value addition. 2023. p. 197-212. [51] Prajapati SK, et al. Antimicrobial application potential of phytoconstituents from turmeric and garlic. In: Bioactive natural products for pharmaceutical applications, 2021: p. 409-435. [52] Zou B, et al. Nanodelivery system of traditional Chinese medicine bioactive compounds: application in the treatment of prostate cancer. Phytomedicine. 2024. https://doi.org/10.1016/j.phymed.2024.155554. [53] Anselmo AC, Mitragotri S. Nanoparticles in the clinic: An update. Bioeng Transl Med. 2019;4(3):e10143. [54] Liu R, et al. Advances of nanoparticles as drug delivery systems for disease diagnosis and treatment. Chin Chem Lett. 2023;34(2):107518. [55] Sharaf S, El-Naggar ME. Wound dressing properties of cationized cotton fabric treated with carrageenan/cyclodextrin hydrogel loaded with honey bee propolis extract. Int J Biol Macromol. 2019;133:583-91. [56] Fadilah NIM, et al. The effect of nanoparticle-incorporated natural-based biomaterials towards cells on activated pathways: a systematic review. Polymers. 2022;14(3):476. [57] Hassanin I, Elzoghby A. Albumin-based nanoparticles: a promising strategy to overcome cancer drug resistance. Cancer Drug Resist. 2020;3(4):930. [58] Vieira, I.R.S. and C.A. Conte-Junior, Nano-delivery systems for food bioactive compounds in cancer: Prevention, therapy, and clinical applications. Critical Reviews in Food Science and Nutrition, 2022: p. 1-26. [59] Canaparo R, et al. Recent developments in antibacterial therapy: focus on stimuli-responsive drug-delivery systems and therapeutic nanoparticles. Molecules. 2019. https://doi.org/10.3390/molecules24101991. [60] Zaidi S, Misba L, Khan AU. Nano-therapeutics: a revolution in infection control in post antibiotic era. Nanomedicine Nanotechnol Biol Med. 2017;13(7):2281-301. [61] Van Giau V, An SSA, Hulme J. Recent advances in the treatment of pathogenic infections using antibiotics and nano-drug delivery vehicles. Drug Des Devel Ther. 2019;13:327-43. [62] Gao W, et al. Nanoparticle approaches against bacterial infections. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2014;6(6):532-47. [63] Angelini P. Plant-Derived Antimicrobials and Their Crucial Role in Combating Antimicrobial Resistance. Antibiotics. 2024;13(8):746. [64] Ogwu MC, Izah SC. Honey as a natural antimicrobial. Antibiotics. 2025. https://doi.org/10.3390/antibiotics14030255. [65] Ingle AP, et al. Recent trends in the development of nano-bioactive compounds and delivery systems. In: Biotechnological production of bioactive compounds. Elsevier; 2020. p. 409-31. [66] Cavallito CJ, Bailey JH. Allicin, the antibacterial principle of Allium sativum. I. Isolation, physical properties and antibacterial action. J Am Chem Soc. 1944;66(11):1950-1. [67] Chavan RD, et al. Assessment of anti-influenza activity and hemagglutination inhibition of Plumbago indica and Allium sativum extracts. Pharmacogn Res. 2016;8(2):105. [68] Farbman KS, et al. Antibacterial activity of garlic and onions: a historical perspective. Pediatr Infect Dis J. 1993;12(7):613. [69] Jonkers D, Sluimer J, Stobberingh E. Effect of garlic on vancomycin-resistant enterococci. Antimicrob Agents Chemother. 1999;43(12):3045. [70] Majewski M. Allium sativum: facts and myths regarding human health. Roczniki Państwowego Zak?adu Higieny. 2014;65(1):89. [71] Curtis H, et al. Broad-spectrum activity of the volatile phytoanticipin allicin in extracts of garlic (Allium sativum L.) against plant pathogenic bacteria, fungi and Oomycetes. Physiol Mol Plant Pathol. 2004;65(2):79-89. [72] Fujisawa H, et al. Antibacterial potential of garlic-derived allicin and its cancellation by sulfhydryl compounds. Biosci Biotechnol Biochem. 2009;73(9):1948-55. [73] Borlinghaus J, et al. Allicin: chemistry and biological properties. Molecules. 2014;19(8):12591-618. [74] Choo S, et al. Antimicrobial properties of allicin used alone or in combination with other medications. Folia Microbiol. 2020;65:451-65. [75] Hashemy, S.I., et al., PEGylated Lecithin-Chitosan-Folic Acid Nanoparticles as Nanocarriers of Allicin for In Vitro Controlled Release and Anticancer Effects. Applied Biochemistry and Biotechnology, 2023: p. 1-17. [76] Rao H, Chong PP, Madhavan P. 3D printing of microbots, characterisation, and utilisation in combination with allicin against C. albicans biofilms. OpenNano. 2023;12:100160. [77] Samborska K, et al. The effect of low-temperature spray drying with dehumidified air on phenolic compounds, antioxidant activity, and aroma compounds of rapeseed honey powders. Food Bioprocess Technol. 2019;12:919-32. [78] Almasaudi S. The antibacterial activities of honey. Saudi J Biol Sci. 2021;28(4):2188-96. [79] Tang JS, et al. Mānuka honey-derived methylglyoxal enhances microbial sensing by mucosal-associated invariant T cells. Food Funct. 2020;11(7):5782-7. [80] Stan D, et al. Natural compounds with antimicrobial and antiviral effect and nanocarriers used for their transportation. Front Pharmacol. 2021;12:723233. [81] Hossain ML, et al. Monitoring the release of Methylglyoxal (MGO) from honey and honey-based formulations. Molecules. 2023;28(6):2858. [82] Matharu RK, et al. Antibacterial properties of honey nanocomposite fibrous meshes. Polymers. 2022;14(23):5155. [83] Mashabela MN, Ndhlovu PT, Mbeng WO. Herbs and Spices’ Antimicrobial Properties and Possible Use in the Food Sector. 2022. [84] Haque MA, Jantan I, Harikrishnan H. Zerumbone suppresses the activation of inflammatory mediators in LPS-stimulated U937 macrophages through MyD88-dependent NF-κB/MAPK/PI3K-Akt signaling pathways. Int Immunopharmacol. 2018;55:312-22. [85] Foong JN, et al. Zerumbone-loaded nanostructured lipid carrier induces apoptosis of canine mammary adenocarcinoma cells. BioMed Res Int. 2018;2018:89. [86] Md S, et al. Development and in vitro evaluation of a zerumbone loaded nanosuspension drug delivery system. Crystals. 2018;8(7):286. [87] da Silva-Buzanello RA, et al. Validation of an ultraviolet-visible (UV-Vis) technique for the quantitative determination of curcumin in poly (l-lactic acid) nanoparticles. Food Chem. 2015;172:99-104. [88] Kianvash N, et al. Evaluation of propylene glycol nanoliposomes containing curcumin on burn wound model in rat: biocompatibility, wound healing, and anti-bacterial effects. Drug Deliv Transl Res. 2017;7(5):654-63. [89] Perera W, et al. Curcumin loaded zinc oxide nanoparticles for activity-enhanced antibacterial and anticancer applications. RSC Adv. 2020;10(51):30785-95. [90] Hajibonabi A, et al. Antimicrobial activity of nanoformulations of carvacrol and thymol: new trend and applications. Open Nano. 2023. https://doi.org/10.1016/j.onano.2023.100170. [91] Marinelli L, Di Stefano A, Cacciatore I. Carvacrol and its derivatives as antibacterial agents. Phytochem Rev. 2018;17:903-21. [92] Sokolik CG, et al. Proteinaceous microspheres as a delivery system for carvacrol and thymol in antibacterial applications. Ultrason Sonochem. 2018;41:288-96. [93] Gafur A, et al. From bulk to nano-delivery of essential phytochemicals: recent progress and strategies for antibacterial resistance. J Mater Chem B. 2020;8(43):9825-35. [94] Punya H, et al. In-vitro evaluation of antimicrobial and antioxidant Efficacy of thyme (Thymus vulgaris L.) essential oil. J Animal Res. 2019;9(3):443-9. [95] Heckler C, et al. Thymol and carvacrol in nanoliposomes: characterization and a comparison with free counterparts against planktonic and glass-adhered Salmonella. LWT. 2020;127:109382. [96] Liolios C, et al. Liposomal incorporation of carvacrol and thymol isolated from the essential oil of Origanum dictamnus L. and in vitro antimicrobial activity. Food Chem. 2009;112(1):77-83. [97] Niaz T, et al. Impact of albumin corona on mucoadhesion and antimicrobial activity of carvacrol loaded chitosan nano-delivery systems under simulated gastro-intestinal conditions. Int J Biol Macromol. 2021;169:171-82. [98] Akhlaq A, et al. Synergistic antibacterial activity of carvacrol loaded chitosan nanoparticles with Topoisomerase inhibitors and genotoxicity evaluation. Saudi J Biol Sci. 2023;30(9):103765. [99] Hao X, et al. pH-responsive allicin-based coatings with antibacterial and antifouling effects in marine environments. Front Mater. 2022;9:852731. [100] Kianvash N, et al. Evaluation of propylene glycol nanoliposomes containing curcumin on burn wound model in rat: biocompatibility, wound healing, and anti-bacterial effects. Drug Deliv Transl Res. 2017;7:654-63. [101] Gao Y, et al. Hyaluronic acid-modified curcumin-copper complex nano delivery system for rapid healing of bacterial prostatitis. Carbohydr Polym. 2023;310:120668. [102] Sun X, Cameron RG, Bai J. Microencapsulation and antimicrobial activity of carvacrol in a pectin-alginate matrix. Food Hydrocolloids. 2019;92:69-73. [103] Liu Q, et al. Formulation optimization and characterization of carvacrol-loaded nanoemulsions: In vitro antibacterial activity/mechanism and safety evaluation. Ind Crop Prod. 2022;181:114816. [104] Shakeri M, Razavi SH, Shakeri S. Carvacrol and astaxanthin co-entrapment in beeswax solid lipid nanoparticles as an efficient nano-system with dual antioxidant and anti-biofilm activities. LWT. 2019;107:280-90. [105] He J, et al. Carvacrol loaded solid lipid nanoparticles of propylene glycol monopalmitate and glyceryl monostearate: preparation, characterization, and synergistic antimicrobial activity. Nanomaterials. 2019;9(8):1162. [106] Luna M, et al. High antibacterial performance of hydrophobic chitosan-based nanoparticles loaded with carvacrol. Colloids Surf, B. 2022;209:112191. [107] Bidyarani N, et al. Synthesis and physicochemical characterization of rhamnolipid-stabilized carvacrol-loaded zein nanoparticles for antimicrobial application supported by molecular docking. J Nanopart Res. 2020;22:1-13. [108] Yilmaz MT, et al. An effective polydopamine coating to improve stability and bioactivity of carvacrol-loaded zein nanoparticles. Int J Food Sci Technol. 2021;56(11):6011-24. [109] Liu Y, et al. Synthesis and properties of core-shell thymol-loaded zein/shellac nanoparticles by coaxial electrospray as edible coatings. Mater Des. 2021;212:110214. [110] Niza E, et al. PEI-coated PLA nanoparticles to enhance the antimicrobial activity of carvacrol. Food Chem. 2020;328:127131. [111] Palange AL, et al. Lipid-polymer nanoparticles encapsulating curcumin for modulating the vascular deposition of breast cancer cells. Nanomedicine. 2014;10(5):e991-1002. [112] Makowski M, et al. Advances in lipid and metal nanoparticles for antimicrobial peptide delivery. Pharmaceutics. 2019;11(11):588. [113] Yeh Y-C, et al. Nano-based drug delivery or targeting to eradicate bacteria for infection mitigation: a review of recent advances. Front Chem. 2020;8:286. [114] Ricci F, et al. Chitosan/sulfobutylether-β-cyclodextrin based nanoparticles coated with thiolated hyaluronic acid for indomethacin ophthalmic delivery. Int J Pharm. 2022;622:121905. [115] Gruber JV, Holtz R, Riemer J. Hyaluronic acid (HA) stimulates the in vitro expression of CD44 proteins but not HAS1 proteins in normal human epidermal keratinocytes (NHEKs) and is HA molecular weight dependent. J Cosmet Dermatol. 2022;21(3):1193-8. [116] Katoh S, et al. A crucial role of sialidase Neu1 in hyaluronan receptor function of CD44 in T helper type 2-mediated airway inflammation of murine acute asthmatic model. Clin Exp Immunol. 2010;161(2):233-41. [117] Gu D, et al. Construction and evaluation of hyaluronic acid-coated flurbiprofen-layered double hydroxide ocular drug delivery system. AAPS PharmSciTech. 2022;23(8):287. [118] Lv F, et al. Apigenin-Mn (II) loaded hyaluronic acid nanoparticles for ulcerative colitis therapy in mice. Front Chem. 2022;10:969962. [119] Mitchell MJ, et al. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021;20(2):101-24. [120] Salmani-Zarchi H, et al. Antimicrobial feature of nanoparticles in the antibiotic resistance era: from mechanism to application. Adv Biomed Res. 2024;13:113. [121] Guo Y, et al. Nanotechnology-based drug delivery systems to control bacterial-biofilm-associated lung infections. Pharmaceutics. 2023. https://doi.org/10.3390/pharmaceutics15112582. [122] Mazumdar S, Chitkara D, Mittal A. Exploration and insights into the cellular internalization and intracellular fate of amphiphilic polymeric nanocarriers. Acta Pharm Sin B. 2021;11(4):903-24. [123] Danaei M, et al. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics. 2018. https://doi.org/10.3390/pharmaceutics10020057. [124] Rahman HS, et al. Zerumbone-loaded nanostructured lipid carriers: preparation, characterization, and antileukemic effect. Int J Nanomedicine. 2013;8:2769-81. [125] Aflakian F, et al. Nanoparticles-based therapeutics for the management of bacterial infections: a special emphasis on FDA approved products and clinical trials. Eur J Pharm Sci. 2023;188:106515. [126] Prabhu RH, Patravale VB, Joshi MD. Polymeric nanoparticles for targeted treatment in oncology: current insights. Int J Nanomedicine. 2015;10:1001-18. [127] Hossen S, et al. Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: a review. J Adv Res. 2019;15:1-18. [128] Ahagh MH, et al. Synthesis, characterization, anti-proliferative properties and DNA binding of benzochromene derivatives: increased Bax/Bcl-2 ratio and caspase-dependent apoptosis in colorectal cancer cell line. Bioorg Chem. 2019;93:103329. [129] Pourmadadi M, et al. Cabazitaxel-nano delivery systems as a cutting-edge for cancer therapy. J Drug Deliv Sci Technol. 2023;82:104338. [130] Pourmadadi M, et al. Macromolecules and nanomaterials loaded with mitomycin C as promising new treatment option cancer drug nanoformulation: a literature review. J Drug Deliv Sci Technol. 2023;87:104835. [131] Pourmadadi M, et al. Nanoparticles loaded with Daunorubicin as an advanced tool for cancer therapy. Eur J Med Chem. 2023;258:115547. [132] Tran S, et al. Cancer nanomedicine: a review of recent success in drug delivery. Clin Transl Med. 2017;6(1):44. [133] Chavda VP, et al. Nano-drug delivery systems entrapping natural bioactive compounds for cancer: recent progress and future challenges. Fron Oncol. 2022;12:62022. [134] Liu M, et al. Nanotechnology-based drug delivery system for anticancer active ingredients from traditional Chinese medicines: a review. Am J Chin Med. 2022;50(8):2011-32. [135] Bozzuto G, et al. Phytocompounds and nanoformulations for anticancer therapy: a review. Molecules. 2024. https://doi.org/10.3390/molecules29163784. [136] Huang M, Lu J-J, Ding J. Natural products in cancer therapy: past, present and future. Nat Prod Bioprospect. 2021;11:5-13. [137] Sahne F, Mohammadi M, Najafpour GD. Single-layer assembly of multifunctional carboxymethylcellulose on graphene oxide nanoparticles for improving in vivo curcumin delivery into tumor cells. ACS Biomater Sci Eng. 2019;5(5):2595-609. [138] Caldas BS, et al. Manufacturing micro/nano chitosan/chondroitin sulfate curcumin-loaded hydrogel in ionic liquid: a new biomaterial effective against cancer cells. Int J Biol Macromol. 2021;180:88-96. [139] Wu Q, et al. Calcium phosphate coated core-shell protein nanocarriers: robust stability, controlled release and enhanced anticancer activity for curcumin delivery. Mater Sci Eng, C. 2020;115:111094. [140] Hussein Y, et al. Enhanced anti-cancer activity by localized delivery of curcumin form PVA/CNCs hydrogel membranes: preparation and in vitro bioevaluation. Int J Biol Macromol. 2021;170:107-22. [141] Motevalli SM, et al. Co-encapsulation of curcumin and doxorubicin in albumin nanoparticles blocks the adaptive treatment tolerance of cancer cells. Biophys Rep. 2019;5:19-30. [142] Pe?alver P, et al. Alkylated resveratrol prodrugs and metabolites as potential therapeutics for neurodegenerative diseases. Eur J Med Chem. 2018;146:123-38. [143] Sharifi-Rad J, et al. Resveratrol-based nanoformulations as an emerging therapeutic strategy for cancer. Front Mol Biosci. 2021;8:649395. [144] Gadag S, et al. Transpapillary iontophoretic delivery of resveratrol loaded transfersomes for localized delivery to breast cancer. Biomaterials Advances. 2022;140:213085. [145] Jangid AK, et al. Inulin-pluronic-stearic acid based double folded nanomicelles for pH-responsive delivery of resveratrol. Carbohydr Polym. 2020;247:116730. [146] Kamel NM, et al. Inhalable dual-targeted hybrid lipid nanocore-protein shell composites for combined delivery of genistein and all-trans retinoic acid to lung cancer cells. ACS Biomater Sci Eng. 2019;6(1):71-87. [147] Shukla RP, et al. Multifunctional hybrid nanoconstructs facilitate intracellular localization of doxorubicin and genistein to enhance apoptotic and anti-angiogenic efficacy in breast adenocarcinoma. Biomater Sci. 2020;8(5):1298-315. [148] Huang B, et al. Functional anti-bone tumor biomaterial scaffold: construction and application. J Mater Chem B. 2023. https://doi.org/10.1039/D3TB00925D. [149] Gao S, et al. Fabrication of pH/photothermal-responsive ZIF-8 nanocarriers loaded with baicalein for effective drug delivery and synergistic chem-photothermal effects. Colloids Surf A Physicochem Eng Asp. 2023;668:131401. [150] Bachimam K, et al. Baicalein nanofiber scaffold containing hyaluronic acid and polyvinyl alcohol: preparation and evaluation. Turk J Med Sci. 2020;50(4):1139-46. [151] Najafabadi AP, et al. pH-sensitive ameliorated quercetin delivery using graphene oxide nanocarriers coated with potential anticancer gelatin-polyvinylpyrrolidone nanoemulsion with bitter almond oil. J Drug Deliv Sci Technol. 2023;82:104339. [152] Zhou M, et al. Polymeric micelles loading with ursolic acid enhancing anti-tumor effect on hepatocellular carcinoma. J Cancer. 2019;10(23):5820. [153] Khwaza V, Oyedeji OO, Aderibigbe BA. Ursolic acid-based derivatives as potential anti-cancer agents: an update. Int J Mol Sci. 2020;21(16):5920. [154] Miatmoko A, et al. Nanoparticles use for delivering ursolic acid in cancer therapy: a scoping review. Front Pharmacol. 2021;12:787226. [155] Seo DY, et al. Ursolic acid in health and disease. Korean J Physiol Pharmacol. 2018;22(3):235. [156] Ou K, et al. Nanodrug carrier based on poly (ursolic acid) with self-anticancer activity against colorectal cancer. Adv Funct Mater. 2020;30(9):1907857. [157] Yang Q-Q, et al. Nanochemoprevention with therapeutic benefits: An updated review focused on epigallocatechin gallate delivery. Crit Rev Food Sci Nutr. 2022;60(8):1243-64. [158] Saha S, et al. Co-delivery nanosystem of epigallocatechin gallate and rutin for anticancer and antibacterial activities. J Drug Deliv Sci Technol. 2022;70:103191. [159] Abdulridha MK, et al. Anticancer effects of herbal medicine compounds and novel formulations: a literature review. J Gastrointest Cancer. 2020;51:765-73. [160] Ghosh S, Das P, Nayak B. High potency EDC-crosslinked bovine serum albumin nanoencapsulation of berberine enhances in vitro anticancer efficacy against glioblastoma by inducing ROS mediated cell apoptosis. New J Chem. 2022;46(48):23254-67. [161] Grebinyk A, et al. C60 fullerene as an effective nanoplatform of alkaloid berberine delivery into leukemic cells. Pharmaceutics. 2019;11(11):586. [162] Rajakumari R, Thomas S, Kalarikkal N. Biomaterials and Its Advances for Delivering Anticancer Drugs. Nanoparticles for Drug Delivery. 2021;89:21-56. [163] Zhou X, et al. Artemisinin-type drugs in tumor cell death: Mechanisms, combination treatment with biologics and nanoparticle delivery. Pharmaceutics. 2022;14(2):395-422. [164] Firouzi Amandi A, et al. Enhanced anti-cancer effect of artemisinin-and curcumin-loaded niosomal nanoparticles against human colon cancer cells. Med Oncol. 2023;40(6):170. [165] Jagwani S, et al. Pharmacokinetic and pharmacodynamic evaluation of resveratrol loaded cationic liposomes for targeting hepatocellular carcinoma. ACS Biomater Sci Eng. 2020;6(9):4969-84. [166] Wang X, et al. Folate-modified erythrocyte membrane nanoparticles loaded with Fe3O4 and artemisinin enhance ferroptosis of tumors by low-intensity focused ultrasound. Front Oncol. 2022;12:864444. [167] Yu Y, et al. Ph-dependent reversibly activatable cell-penetrating peptides improve the antitumor effect of artemisinin-loaded liposomes. J Colloid Interface Sci. 2021;586:391-403. [168] Zafar S, Jain GK, Ahmad FJ. Nanomedicine approaches for the delivery of herbal anticancer drugs. Nanomed Bioactives. 2020;8:201-29. [169] Zhu Y, et al. Multifunctional ginsenoside Rg3-based liposomes for glioma targeting therapy. J Control Release. 2021;330:641-57. [170] Yue PY, et al. The angiosuppressive effects of 20 (R)-ginsenoside Rg3. Biochem Pharmacol. 2006;72(4):437-45. [171] Choi YJ, et al. Ginsenoside Rg3 induces apoptosis in the U87MG human glioblastoma cell line through the MEK signaling pathway and reactive oxygen species. Oncol Rep. 2013;30(3):1362-70. [172] Shan X, et al. Ginsenoside Rg3 inhibits melanoma cell proliferation through down-regulation of histone deacetylase 3 (HDAC3) and increase of p53 acetylation. PLoS ONE. 2014;9(12):e115401. [173] Wang J-H, et al. 20 (s)-ginsenoside Rg3 promotes apoptosis in human ovarian cancer HO-8910 cells through PI3K/Akt and XIAP pathways. Tumor Biol. 2014;35:11985-94. [174] Lu SL, et al. Graphene oxide nanoparticle-loaded ginsenoside Rg3 improves photodynamic therapy in inhibiting malignant progression and stemness of osteosarcoma. Front Mol Biosci. 2021;8:663089. [175] Sebastiammal S, et al. Curcumin-encased hydroxyapatite nanoparticles as novel biomaterials for antimicrobial, antioxidant and anticancer applications: a perspective of nano-based drug delivery. J Drug Deliv Sci Technol. 2020;57:101752. [176] Ramezani Farani M, et al. Folic acid-adorned curcumin-loaded iron oxide nanoparticles for cervical cancer. ACS Appl Bio Mater. 2022;5(3):1305-18. [177] Guo X, et al. Redox-responsive lipidic prodrug nano-delivery system improves antitumor effect of Curcumin derivative C210. Pharmaceutics. 2023;15(5):1546. [178] Dehghani S, et al. Multifunctional MIL-Cur@FC as a theranostic agent for magnetic resonance imaging and targeting drug delivery: in vitro and in vivo study. J Drug Target. 2020;28(6):668-80. [179] Laha D, et al. Fabrication of curcumin-loaded folic acid-tagged metal organic framework for triple negative breast cancer therapy in in vitro and in vivo systems. New J Chem. 2019;43(1):217-29. [180] Yang Z, et al. Fabrication of zein-carboxymethyl cellulose nanoparticles for co-delivery of quercetin and resveratrol. J Food Eng. 2023;341:111322. [181] Meng J, et al. Combination therapy using co-encapsulated Resveratrol and Paclitaxel in liposomes for drug resistance reversal in breast cancer cells in vivo. Sci Rep. 2016;6(1):22390. [182] Ghasemi Goorbandi R, Mohammadi MR, Malekzadeh K. Synthesizing efficacious genistein in conjugation with superparamagnetic Fe3O4 decorated with bio-compatible carboxymethylated chitosan against acute leukemia lymphoma. Biomater Res. 2020;24(1):1-13. |